Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports the efficacy and safety findings of inhaled insulin for patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED